NFKB1 and breast cancer: To examine this further, we knocked down Nrps in breast cancer cell lines with siRNA, and found this prevented tumor sphere (mammosphere) formation, which is an in vitro assay for breast CSCs, and abrogated constitutive NF-κB activation [152].